Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.25 USD | +1.56% | +15.66% | -58.12% |
Apr. 18 | MyMD Pharmaceuticals, Inc. Announces Resignation of Adam Kaplin as Chief Scientific Officer | CI |
Apr. 09 | Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.17M |
---|---|---|---|---|---|
Net income 2022 | -15M | Net income 2023 | -4M | EV / Sales 2022 | - |
Net cash position 2022 | 4.69M | Net cash position 2023 | 4.87M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.94
x | P/E ratio 2023 |
-1.46
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
1 day | +1.56% | ||
1 week | +15.66% | ||
Current month | +5.52% | ||
1 month | +46.40% | ||
3 months | -22.62% | ||
6 months | -72.57% | ||
Current year | -58.12% |
Managers | Title | Age | Since |
---|---|---|---|
President | 71 | 20-10-31 | |
Ian Rhodes
DFI | Director of Finance/CFO | 51 | 21-04-14 |
Director/Board Member | 58 | 17-08-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 17-08-07 | |
President | 71 | 20-10-31 | |
Joshua Silverman
CHM | Chairman | 53 | 18-09-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 3.25 | +1.56% | 28 335 |
24-05-01 | 3.2 | +3.90% | 134,894 |
24-04-30 | 3.08 | +6.21% | 79,669 |
24-04-29 | 2.9 | +2.11% | 45,070 |
24-04-26 | 2.84 | +1.07% | 17,442 |
Delayed Quote Nasdaq, May 02, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-58.12% | 6.9M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- MYMD Stock